Correspondence 0001437749-24-000942 from GeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc.
Date: Jan. 9, 2024 · CIK: 0000832489 · Accession: 0001437749-24-000942
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276345
Letter
govx20240109_corresp.htm
GeoVax Labs, Inc.
1900 Lake Park Drive
Suite 380
Smyrna, Georgia 30080
(678) 384-7220
January 9, 2024
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Re:
GeoVax Labs, Inc.
Registration Statement on Form S-1
File No. 333-276345
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the registration statement on Form S-1 (File No. 333-276345) filed with the U.S. Securities and Exchange Commission on January 2, 2024, be accelerated so that the registration statement becomes effective at 5:00 p.m. Eastern Time on Thursday, January 11, 2024 or as soon thereafter as practicable. In this regard, the Registrant is aware of its obligations under the Securities Act.
If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com.
Very truly yours,
GeoVax Labs, Inc.
Show Raw Text
CORRESP 1 filename1.htm govx20240109_corresp.htm GeoVax Labs, Inc. 1900 Lake Park Drive Suite 380 Smyrna, Georgia 30080 (678) 384-7220 January 9, 2024 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: GeoVax Labs, Inc. Registration Statement on Form S-1 File No. 333-276345 Ladies and Gentlemen: In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the registration statement on Form S-1 (File No. 333-276345) filed with the U.S. Securities and Exchange Commission on January 2, 2024, be accelerated so that the registration statement becomes effective at 5:00 p.m. Eastern Time on Thursday, January 11, 2024 or as soon thereafter as practicable. In this regard, the Registrant is aware of its obligations under the Securities Act. If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com. Very truly yours, GeoVax Labs, Inc. By: /s/ Mark W. Reynolds Mark W. Reynolds Chief Financial Officer